Business Context and Reporting Period
Company: Tradeweb Markets Inc.
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2024 (Q3 2024)
Business Overview: Tradeweb operates electronic marketplaces for trading rates, credit, equities, and money markets. The company serves institutional, wholesale, retail, and corporate clients globally. It is a consolidating subsidiary of London Stock Exchange Group (LSEG).
Key Financial Metrics
| Metric (in thousands, except per share) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenue | $448,915 | $328,357 | $1,262,605 | $968,219 |
| Operating Income | $159,316 | $124,738 | $489,488 | $363,639 |
| Net Income (GAAP) | $130,223 | $111,630 | $410,021 | $315,762 |
| Net Income Attributable to Tradeweb | $113,916 | $98,614 | $359,297 | $275,552 |
| Diluted EPS (Attributable to Tradeweb) | $0.53 | $0.46 | $1.67 | $1.30 |
| Adjusted EBITDA | $239,816 | $170,360 | $675,877 | $505,618 |
| Adjusted EBITDA Margin | 53.4% | 51.9% | 53.5% | 52.2% |
| Free Cash Flow (9M) | $564,805 | $451,756 | ||
| Cash and Cash Equivalents (Sep 30, 2024) | $1,173,734 | |||
| Debt Outstanding | None (Revolving Credit Facility: $0 outstanding) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 36.7% in Q3 2024 and 30.4% for the nine months ended September 30, 2024, compared to the prior year periods. Growth was driven by higher trading volumes in rates derivatives, U.S. corporate bonds, and government bonds.
- Acquisitions:
- ICD Acquisition: Closed August 1, 2024, for approximately $774.5 million (net of cash). Added a new "Corporates" client sector and contributed $17.2 million in revenue in Q3.
- r8fin Acquisition: Closed January 19, 2024, for $125.9 million. Enhanced algorithmic trading capabilities.
- Expense Increases: Total expenses rose 42.2% in Q3 2024. Key drivers included:
- Employee Compensation: Increased 38.1% due to higher incentive compensation, headcount growth, and $2.4 million in accelerated stock-based compensation related to the departure of the former President.
- Depreciation & Amortization: Increased 24.3% due to amortization of assets from recent acquisitions.
- General & Administrative: Increased 204.7% primarily due to an $8.7 million swing in foreign exchange results (losses in Q3 2024 vs. gains in Q3 2023).
- Trading Volumes: Total average daily volume (ADV) increased 55.3% to $2.21 trillion in Q3 2024, with significant growth in Rates Derivatives (+63.0%) and Money Markets (+62.5%).
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects total cash paid for capital expenditures and software development costs for fiscal year 2024 to be between $77 million and $85 million (excluding acquisition cash payments).
- Dividends: The Board declared a quarterly cash dividend of $0.10 per share for Q4 2024, payable December 16, 2024.
- Share Repurchases: Under the 2022 Share Repurchase Program ($300 million authorization), the company repurchased 214,795 shares for $25.0 million in Q3 2024. Approximately $214.8 million remains available.
- Tax Receivable Agreement (TRA): The company has a liability of $382.4 million under the TRA, with payments expected to be significant over the next 15 years. A $0.9 million expense was recognized in Q3 2024 due to changes in estimated future tax savings related to the ICD acquisition.
- Risks:
- Market Volatility: Lower volatility may reduce trading volumes and revenue.
- Regulatory Environment: Extensive regulation in the U.S. and internationally could increase compliance costs.
- Cybersecurity: Continued investment required to mitigate cyber threats.
- Foreign Currency: Fluctuations in exchange rates (primarily Euro and British Pound) impact reported revenue and expenses.
Key Facts for Investor Verification
- Acquisition Integration: Verify the revenue contribution and integration progress of the ICD acquisition, which represents a new client sector (Corporates) and a significant portion of recent revenue growth.
- Non-GAAP Adjustments: Review the reconciliation of GAAP Net Income to Adjusted EBITDA and Adjusted Net Income, specifically the exclusions for stock-based compensation related to executive departures and acquisition-related transaction costs.
- Foreign Exchange Impact: Assess the volatility of foreign exchange gains/losses, which caused a significant swing in General and Administrative expenses between Q3 2023 and Q3 2024.
- Tax Receivable Agreement Liability: Monitor the $382.4 million TRA liability and the impact of future LLC Interest exchanges on cash flow requirements.
- Failed Settlement Transactions: Note the $297.8 million receivable and $286.2 million payable related to failed settlement transactions as of September 30, 2024, which were fully settled in October 2024.